Ocular tissue permeabilities

International Ophthalmology Clinics

Volumn 44, Issue 3, 2004, Pages 53-61

  Lawrence, Matthew S ^a   Miller, Joan W ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 SULFOBENZOATE; BENZOIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; MANNITOL; UNCLASSIFIED DRUG;

CONJUNCTIVA; CORNEA EPITHELIUM; CORNEA PERMEABILITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG ELIMINATION; DRUG PENETRATION; EYE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCLERA;

CONJUNCTIVA; CORNEA; DRUG DELIVERY SYSTEMS; HUMANS; PERMEABILITY; PHARMACOKINETICS; SCLERA;

EID: 3242708419     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-200404430-00008     Document Type: Review

References (39)

1. Worakul N, Nursen U, Robinson JR. Ocular pharmacokinetics. In: Albert D and Jakobiec F, ed. Principles and Practices of Ophthalmology. Philadelphia, PA: W.B. Saunders; 1999:202-211.
2. Lee VH, Robinson JR. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J Pharm Sci. 1979;68:673-684.
3. Lee VH, Robinson JR. Topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol. 1986;2:67-108.
4. Chien DS, Sasaki H, Bundgaard H, et al. Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit. Pharm Res. 1991;8:728-733.
5. Nagataki S, Mishima S. Pharmacokinetics of instilled drugs in the human eye. Int Ophthalmol Clin. 1980;20:33-49.
6. Doane MG, Jensen AD, Dohlman CH. Penetration routes of topically applied eye medications. Am J Ophthalmol. 1978;85:383-386.
7. Ahmed I, Patton TF. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci. 1985;26:584-587.
8. Grass GM, Robinson JR. Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics. J Pharm Sci. 1988;77:3-14.
9. Hamalainen KM, Kananen K, Auriola S, et al. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Vis Sci. 1997;38:627-634.
10. Tonjum AM. Permeability of horseradish peroxidase in the rabbit corneal epithelium. Acta Ophthalmol. 1974;52:650-658.
11. Sasaki H, Yamamura K, Tei C, et al. Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug. J Drug Target. 1995;3:129-135.
12. Wang W, Sasaki H, Chien DS, et al. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. Curr Eye Res. 1991;10:571-579.
13. Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87:1479-1488.
14. Joshi A, Maurice D, Paugh JR. A new method for determining corneal epithelial barrier to fluorescein in humans. Invest Ophthalmol Vis Sci. 1996;37:1008-1016.
15. Kessler C, Bleckmann H, Kleintges G. Influence of the strength, drop size and viscosity of metipranolol eye drops on the concentration of the substance in human aqueous humour. Graefes Arch Clin Exp Ophthalmol. 1991;229:452-456.
16. Lee VH, Carson LW, Kashi SD, et al. Metabolic and permeation barriers to the ocular absorption of topically applied enkephalins in albino rabbits. J Ocul Pharmacol. 1986;2:345-352.
17. Ahmed I, Gokhale RD, Shah MV, et al. Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea. J Pharm Sci. 1987;76:583-586.
18. Wei ZG, Wu RL, Lavker RM, et al. In vitro growth and differentiation of rabbit bulbar, fornix, and palpebral conjunctival epithelia. Implications on conjunctival epithelial transdifferentiation and stem cells. Invest Ophthalmol Vis Sci. 1993;34:1814-1828.
19. Sasaki H, Igarashi Y, Nagano T, et al. Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers. Pharm Res. 1995;12:1146-1150.
20. Urtti A, Salminen L. Concentration-dependent precorneal loss of pilocarpine in rabbit eyes. Acta Ophthalmol (Copenh). 1985;63:502-506.
21. Lee VH, Carson LW. Ocular disposition of inulin from single & multiple doses of positively charged multilamellar liposomes: evidence for alterations in tear dynamics and ocular surface characteristics. J Ocul Pharmacol. 1986;2:353-364.
22. Chien DS, Homsy JJ, Gluchowski C, et al. Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes. Curr Eye Res. 1990;9:1051-1059.
23. Huang AJ, Tseng SC, Kenyon KR. Paracellular permeability of corneal and conjunctival epithelia. Invest Ophthalmol Vis Sci. 1989;30:684-689.
24. Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41:1181-1185.
25. Edward A, Prausnitz MR. Predicted permeability of the cornea to topical drugs. Pharm Res. 2001;18:1497-1508.
26. Olsen TW, Edelhauser HF, Lim JI, et al. Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Ophthalmol Vis Sci. 1995;36:1893-1903.
27. Maurice DM, Polgar J. Diffusion across the sclera. Exp Eye Res. 1977;25:577-582.
28. Mishima S. Clinical pharmacokinetics of the eye. Proctor lecture. Invest Ophthalmol Vis Sci. 1981;21:504-541.
29. Xu J, Heys JJ, Barocas VH, et al. Permeability and diffusion in vitreous humor: implications for drug delivery. Pharm Res. 2000;17:664-669.
30. Ohtori A, Tojo K. In vivo/in vitro correlation of intravitreal delivery of drugs with the help of computer simulation. Biol Pharm Bull. 1994;17:283-290.
31. Marmor MF, Negi A, Maurice DM. Kinetics of macromolecules injected into the subretinal space. Exp Eye Res. 1985;40:687-696.
32. Maurice DM. Drug delivery to the posterior segment from drops. Surv Ophthalmol. 2002;47(suppl 1):S41-S52.
33. Eguchi S, Araie M, Takase M. Movement of fluorescein and fluorescein glucuronide across the isolated rabbit iris-ciliary body. Jpn J Ophthalmol. 1987;31:440-454.
34. Macdonald EA, Maurice DM. Loss of fluorescein across the conjunctiva. Exp Eye Res. 1991;53:427-430.
35. Holm O. A photogrammetric method for estimation of the pupillary aqueous flow in the living human eye. I. Acta Ophthalmol. 1968;46:254-277.
36. Ambati J, Gragoudas ES, Miller JW, et al. Transscleral delivery of bioactive protein to the choroid and retina. Invest Ophthalmol Vis Sci. 2000;41:1186-1191.
37. Kim TW, Lindsey JD, Aihara M, et al. Intraocular distribution of 70-kDa dextran after subconjunctival injection in mice. Invest Ophthalmol Vis Sci. 2002;43:1809-1816.
38. Lincoff H, Stanga P, Movshovich A, et al. Choroidal concentration of interferon after retrobulbar injection. Invest Ophthalmol Vis Sci. 1996;37:2768-2771.
39. Olsen TW, Aaberg SY, Geroski DH, et al. Human sclera: thickness and surface area. Am J Ophthalmol. 1998;125:237-241.